ASA study for cancer prevention interesting but leaves out large studies stating the opposite and uses studies not originally designed for cancer outcomes

Dr. Barry Dworkin

Madely Health Headlines Commentary for March 21, 2012

 

[display_podcast]

 

Source:

More research touts aspirin for cancer prevention

Reference:

Aspirin Benefits May Include Cancer Prevention

 

Primary source: The Lancet
Source reference:
Rothwell PR, et al “Short-term effects of daily aspirin on cancer incidence, mortalilty, and nonvascular death: Analysis of the time course of risks and benefits in 51 randomized controlled trials” Lancet 2012; DOI: 10.1016/S01450-6736(11)61720-0.

Additional source: The Lancet
Source reference:
Rothwell PM, et al “Effect of daily aspirin on risk of cancer metastasis: A study of incident cancers during randomized controlled trials” Lancet 2012; DOI: 10.1016/S0140-6736(12)60209-8.

Additional source: The Lancet Oncology
Source reference:
Rothwell PM, et al “Effects of regular aspirin on long-term cancer incidence and metastasis: A systematic comparison of evidence from observational studies versus randomized trials” Lancet Oncol 2012; DOI: 10.1016/S1470-2045(12)70112-2.

Related posts:

  1. Aspirin use improves colon cancer survival for those who have a specific mutation called PIK3CA
  2. Meta-analysis cannot recommend ASA for primary prevention of heart disease and cancer in otherwise health people 50 years and up for lack of conclusive evvidence
  3. Report cannot prove that obesity increases colorectal cancer risk
  4. Processed red meat identified to increase risk of colon cancer but risk needs to taken in context